Invitation to join the presentation of the C-RAD Year-end report 2021 Date: Thursday January 27, 2022 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Year-end report 2021 Procedure: Please…
Read More
Invitation to join the presentation of the C-RAD Year-end report 2021 Date: Thursday January 27, 2022 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Year-end report 2021 Procedure: Please…
C-RAD har idag emottagit en inköpsorder från det belgiska företaget Ion Beam Applications SA (IBA) avseende leverans av flertalet Catalyst™ och Sentinel™ 4DCT system, samt ett flerårigt serviceavtal. C-RAD och…
C-RAD announced today a purchase order from the Belgium company Ion Beam Applications SA (IBA) to supply multiple Catalyst™ and Sentinel™ 4DCT systems as well as a multiyear service agreement….
C-RAD is pleased to announce that Catalyst+ HD™ has been successfully validated at the MVZ Prof. Dr. Uhlenbrock & Partner, Medical Centre in Dortmund, Germany for use with their new…
THIRD QUARTER 2021 Order intake increased 2% to 82.1 (80.5) MSEK (8% in constant currencies) Order backlog amounted to 372.2 (305.8) MSEK. Revenue increased 20% to 63.2 (52.6) MSEK (25%…
TREDJE KVARTALET 2021 • Orderingången ökade med 2% till 82,1 (80,5) MSEK (8% i konstanta valutor). • Orderstocken uppgick till 372,2 (305,8) MSEK. • Intäkterna ökade med 20% till 63,2…
Invitation to join the presentation of the C-RAD Q3 interim report Date: Thursday October 28, 2021 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Interim Report Q3 2021 Procedure:…
Invitation to join the presentation of the C-RAD Q3 interim report Date: Thursday October 28, 2021 / kl. 11:00 CET Venue: Online Presentation Topic: C-RAD Interim Report Q3 2021 Procedure:…
C-RAD AB and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to enhance the Accuray Radixact® System’s ability to treat breast cancer. The companies will partner…